| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/10/2007 | CN1894237A Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 01/10/2007 | CN1894236A Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication |
| 01/10/2007 | CN1894234A 二肽基肽酶抑制剂 Dipeptidyl peptidase inhibitors |
| 01/10/2007 | CN1894233A Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2h-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them |
| 01/10/2007 | CN1894232A Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 01/10/2007 | CN1894231A Furan derivatives as ep4 receptor antagonists |
| 01/10/2007 | CN1894227A Phenylpiperazine cycloalkanol derivatives and methods of their use |
| 01/10/2007 | CN1894226A Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 01/10/2007 | CN1894225A (3,4-disubstituted)propanoic carboxylates as SLP (EDG) receptor agonists |
| 01/10/2007 | CN1894222A Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 01/10/2007 | CN1894221A Reference standard for characterization of rosuvastatin |
| 01/10/2007 | CN1894217A Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors |
| 01/10/2007 | CN1894215A Compounds for treatment of cell proliferative diseases |
| 01/10/2007 | CN1894214A New 5,6-dihydropyrin-2-one compounds useful as inhibitors of thrombin |
| 01/10/2007 | CN1894213A Substituted tetrahydrocarbazole and cyclopentanoindole derivatives |
| 01/10/2007 | CN1894210A Prolinylarylacetamides |
| 01/10/2007 | CN1894206A N-substituted-N-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 01/10/2007 | CN1894200A Omega substituted naphthyloxy-amino alkane den-ivative used as anti-hyperglycaemia agent and its preparation therefor |
| 01/10/2007 | CN1894195A Ether compounds and compositions for cholesterol management and related uses |
| 01/10/2007 | CN1893989A Crosslinked hyaluronic acid compositions for tissue augmentation |
| 01/10/2007 | CN1893982A Menthol-containing preparation |
| 01/10/2007 | CN1893978A Combinations for HCV treatment |
| 01/10/2007 | CN1893977A Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient. |
| 01/10/2007 | CN1893966A Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 01/10/2007 | CN1893959A Enhancement of magnesium uptake in mammals |
| 01/10/2007 | CN1893958A Nucleic acid and corresponding protein entitle 98P4B6 useful in treatment and detection of cancer |
| 01/10/2007 | CN1893957A Nitric oxide donating derivatives for the treatment of cardiovascular disorders |
| 01/10/2007 | CN1893956A Doxycycline metal complex in a solid dosage form |
| 01/10/2007 | CN1893955A Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases |
| 01/10/2007 | CN1893954A Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and derivatives |
| 01/10/2007 | CN1893953A Tricyclic 1-((3-indol-3-yl)carbonyl)piperazine derivatives as cannabinoid cb1 receptor agonists |
| 01/10/2007 | CN1893952A Pyrrolo[2,3-D]pyrimidine compounds for treating transplant rejection |
| 01/10/2007 | CN1893951A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 01/10/2007 | CN1893950A Methods of treating acute inflammation in animals with p38 map kinase inhibitors |
| 01/10/2007 | CN1893949A Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 01/10/2007 | CN1893948A Muscarinic acetylcholine receptor antagonists |
| 01/10/2007 | CN1893947A Use of siramesine in the treatment of cancer |
| 01/10/2007 | CN1893946A Use of a pyrazole derivative for preparing medicaments for the prevention and the treatment of dyslipidemia and illnesses associated with dyslipidemia and/or obesity |
| 01/10/2007 | CN1893945A 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 01/10/2007 | CN1893944A 3-cyano-quinoline derivatives with antiproliferative activity |
| 01/10/2007 | CN1893943A Pyrazolopyridines and analogs thereof |
| 01/10/2007 | CN1893942A Use of gaboxadol for treating insomnia |
| 01/10/2007 | CN1893941A Fused-ring compounds and use thereof as drugs |
| 01/10/2007 | CN1893940A Use of ondansetron for the treatment of inflammation, and pharmaceutical compositions thereof |
| 01/10/2007 | CN1893939A Composition for preventing and treating hepatoma |
| 01/10/2007 | CN1893938A 普瑞巴林组合物 Pregabalin composition |
| 01/10/2007 | CN1893937A Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity |
| 01/10/2007 | CN1893936A ((((1h-indol-3yl) methylidene)amino)oxy)acetic acid derivatives and related compounds as pai-1 inhibitors for the treatment of inpairement of the fibrinolytic system and of thrombosis |
| 01/10/2007 | CN1893935A The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist |
| 01/10/2007 | CN1893934A Use of sphingosine-1-phosphate (s1p) receptor agonists for the treatment of brain degenerative diseases |
| 01/10/2007 | CN1893933A Materials and methods for improving alcohol metabolism and alleviating the effects of hangovers |
| 01/10/2007 | CN1893932A Microemulsion preconcentrate comprising a renin inhibitor |
| 01/10/2007 | CN1893929A Extended release venlafaxine formulation |
| 01/10/2007 | CN1893926A Stable liposome compositions comprising lipophilic amine containing pharmaceutical agents |
| 01/10/2007 | CN1893925A In vivo targeting of dendritic cells |
| 01/10/2007 | CN1893923A Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs |
| 01/10/2007 | CN1893921A Pharmaceutical compositions |
| 01/10/2007 | CN1893920A Effervescent preparation of a basic medicinally active substance |
| 01/10/2007 | CN1893919A Endoparasiticidal agents for topical application |
| 01/10/2007 | CN1893909A Composition for improving skin, hair and coat health containing flavanones |
| 01/10/2007 | CN1893839A Nutritional composition for wound healing |
| 01/10/2007 | CN1893837A Serum remnant-like lipoprotein concentration regulator |
| 01/10/2007 | CN1893827A Silver dihydrogen citrate compositions comprising a second antimicrobial agent |
| 01/10/2007 | CN1893825A Substituted arylpyrazoles as parasiticidal agents |
| 01/10/2007 | CN1891825A Gene and protein relating to hepatocellular carcinoma |
| 01/10/2007 | CN1891703A Chelerythrine compound and its preparing method |
| 01/10/2007 | CN1891701A Heteraromatic ring thiosemicarbazone compound, and its derivatives and their use forpreparing antitumour medicine |
| 01/10/2007 | CN1891699A Therapeutic morpholino-substituted compounds |
| 01/10/2007 | CN1891693A Therapeutic morpholino-substituted compounds |
| 01/10/2007 | CN1891687A Inflammatory factor receptor antagonistic active compound from microbe and its use |
| 01/10/2007 | CN1891303A Method for preparing bile acid adsorbent of beta cyclo dextrin polymer |
| 01/10/2007 | CN1891302A Drug carrier and method for preparing same |
| 01/10/2007 | CN1891300A Benzocaine film-formed gel composition and its use |
| 01/10/2007 | CN1891298A Drug depot for parenteral drug release, in particular intravascular drug release |
| 01/10/2007 | CN1891297A Medicinal composition containing angiotensin II receptor agonist and fibric acid compound |
| 01/10/2007 | CN1891296A Medicinal composition containing calcium agonist and phenoxy acid compound |
| 01/10/2007 | CN1891287A Nano compound musk injection preparion, and its preparing method |
| 01/10/2007 | CN1891279A Capsule for treating cardio-cerebrovasular disease |
| 01/10/2007 | CN1891271A Qingkailing tablet and its preparing method |
| 01/10/2007 | CN1891270A Burn-empyrosis-wound-sore oil, and its compounding method and use |
| 01/10/2007 | CN1891266A Chinese medicine oral disintegrating tablet for treating angina pectoris, and its preparing method |
| 01/10/2007 | CN1891263A Use of medicinal composition containing red paeony root for preparing medicinefor treating chronic blood shortage to brain |
| 01/10/2007 | CN1891260A Corydalis decumbens extract, and its preparing method and use |
| 01/10/2007 | CN1891259A External-use Chinese medicine preparation for treating bromhidrosis |
| 01/10/2007 | CN1891257A Medicinal composition for treating odontia, and its preparing method |
| 01/10/2007 | CN1891253A Effervescent tablet of straworm fruit bacteria sugar |
| 01/10/2007 | CN1891241A Chinese medicine capsule and preparation |
| 01/10/2007 | CN1891238A Method for preparing nutrient liquid containing nucleic acid and nucleic acid raw material using biological cell |
| 01/10/2007 | CN1891229A Medicinal composition for preventing or treating metabolic syndrome |
| 01/10/2007 | CN1891228A Baicalin dropping pill and its preparing method |
| 01/10/2007 | CN1891227A 偏诺皂苷类化合物注射制剂 Partial promise saponin compound injectable formulations |
| 01/10/2007 | CN1891226A 偏诺皂苷类化合物注射制剂 Partial promise saponin compound injectable formulations |
| 01/10/2007 | CN1891225A Adefovir dipivoxil self-emulsifiable preparation and its preparing method |
| 01/10/2007 | CN1891224A Progestational hormone composition, and its slow-release suppository device and preparation of said device |
| 01/10/2007 | CN1891223A Medicine containing forrest silk vine root orherb aglycone, and its preparing method and use |
| 01/10/2007 | CN1891222A Medicinal composition containing enalapril or genazepril and sotalol |
| 01/10/2007 | CN1891221A Combination therapy to treat hepatitis b virus |
| 01/10/2007 | CN1891220A 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 01/10/2007 | CN1891219A Medicinal composition containing rosuvastatin or pitavastatin and B clan vitamin |
| 01/10/2007 | CN1891218A Ranolazine hydrochloride slow-release preparation and its preparing method |